用kaftrio治疗的囊性纤维化儿科患者的现实生活:一项描述性观察性研究
Francisco José García Díaz1, María Moreno Ortega1, Marcos Medina Bethencourt1
1Servicio de Pediatría, Hospital Universitario Virgen del Rocío, Sevilla, España.
Clinical pediatrics
|April 12, 2025
概括
卡夫特里奥 (Elexacaftor,Tezacaftor,Ivacaftor) 在1年内显著改善了儿科囊性纤维化患者的肺功能和体重指数. 治疗还降低了汗液中的化物水平,表明整体健康状况更好.
科学领域:
- 医学研究 医学研究
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 囊性纤维化 (CF) 是一种影响多个器官的遗传性疾病.
- 埃莱克萨卡夫托,特扎卡夫托和伊瓦卡夫托的联合疗法Kaftrio于2020年被批准用于12岁及以上的CF患者.
- 了解卡夫特里奥对儿科患者的长期影响至关重要.
研究的目的:
- 评估儿童CF患者Kaftrio治疗一年的临床结果.
- 为了比较治疗开始前和之后的临床特征.
- 评估Kaftrio对青少年肺功能,汗液化物水平和BMI的影响.
主要方法:
- 观察性,描述性和纵向研究设计.
- 包括患有至少一个F508del突变的儿科CF患者 (12岁以上).
- 数据收集包括肺功能测试 (FEV1,FVC,MMEF),汗液化物水平,以及治疗前后的BMI z-scores.
主要成果:
- 在肺功能中观察到显著改善:FEV1z-score (+1.1),FVC (+0.56) 和MMEF 25/75 (+1.53).
- 汗液中化物水平显著降低了25.50点.
- 在61.53%的患者中,BMI-for-age z-score (+0.39) 的增加和咳/分泌物的短暂增加.
结论:
- 在儿童CF患者中,Kaftrio在改善肺功能和营养状况 (BMI) 中表现出显著的疗效.
- 该疗法有效降低了汗液化物水平,这是CF的一个关键生物标志物.
- 虽然一般耐受性很好,但在开始时可能会出现过渡性呼吸道症状.
更多相关视频
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.2K
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
6.8K
相关概念视频
01:24Cystic Fibrosis: Management
110
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
110
01:23Cystic Fibrosis: Pathogenesis
148
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
148